D. Integlia
发表
A. Migliore,
E. Bizzi,
D. Integlia,
2015,
Medical hypotheses.
A. Nicolaides,
S. Kakkos,
D. Integlia,
2021,
Phlebology.
J. Raffetto,
G. Palareti,
D. Integlia,
2020,
TH Open.
L. Petrella,
A. Migliore,
V. Bruzzese,
2016,
BioDrugs.
A. Migliore,
B. Frediani,
D. Integlia,
2020,
European review for medical and pharmacological sciences.
A. Morabito,
D. Integlia,
D. Cortinovis,
2022,
Global & regional health technology assessment.
A. Migliore,
D. Integlia,
E. Alemao,
2021,
Therapeutic advances in musculoskeletal disease.
F. Di Giuseppe,
A. Migliore,
D. Integlia,
2019,
ClinicoEconomics and outcomes research : CEOR.
A. Migliore,
F. D. Giuseppe,
D. Integlia,
2019
.
A. Migliore,
D. Integlia,
S. Broccoli,
2015,
Value in Health.
D. Integlia,
G. Pompilio,
2022,
Global & Regional Health Technology Assessment.
Meta-analyses of sulodexide and other drugs in prevention and treatment of post-thrombotic syndrome.
M. Monreal,
D. Integlia,
R. Pesavento,
2022,
European review for medical and pharmacological sciences.
L. Petrella,
A. Migliore,
V. Bruzzese,
2016,
BioDrugs.
G. Baio,
F. Pammolli,
D. Integlia,
2009
.
A. Migliore,
D. Integlia,
U. Massafra,
2021,
European review for medical and pharmacological sciences.
A. Migliore,
B. Frediani,
D. Integlia,
2021,
European review for medical and pharmacological sciences.